What is Theravance Biopharma's investment purchases?

Theravance Biopharma (TBPH) reported investment purchases of $43.41M in Q1 2026.

How has Theravance Biopharma's investment purchases changed year-over-year?

Theravance Biopharma's investment purchases increased by 2105.6% year-over-year, from $1.97M to $43.41M.

What is the long-term trend for Theravance Biopharma's investment purchases?

Over 3 years (2021 to 2025), Theravance Biopharma's investment purchases has grown at a 16.2% compound annual growth rate (CAGR), from $158.31M to $248.22M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Theravance Biopharma TBPH Investment Purchases

Investment Purchases at other companies

Zevra Therapeutics, Inc.ZVRA

$58.3M+692%

United TherapeuticsUTHR

$701.7M+1.4%

PrecigenPGEN

$33.87M+225%

Ultragenyx PharmaceuticalRARE

$131M—

Mirum Pharmaceuticals, Inc.MIRM

$34.8M+3.8%

BridgeBio PharmaBBIO

$52.67M—

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$896.51M+68.7%

Enterprise value$648.91M+38.3%

P/E7.8×—

P/S8.2×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's investment purchases?: Theravance Biopharma (TBPH) reported investment purchases of $43.41M in Q1 2026.
How has Theravance Biopharma's investment purchases changed year-over-year?: Theravance Biopharma's investment purchases increased by 2105.6% year-over-year, from $1.97M to $43.41M.
What is the long-term trend for Theravance Biopharma's investment purchases?: Over 3 years (2021 to 2025), Theravance Biopharma's investment purchases has grown at a 16.2% compound annual growth rate (CAGR), from $158.31M to $248.22M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.